Latest Drotrecogin alfa Stories

2013-07-19 23:20:23

The DrugRisk Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) July 19, 2013 The prescription drug safety advocates at DrugRisk.com are announcing new information for patients taking the blood thinner Pradaxa. As litigation over alleged internal bleeding injuries grows, a recent study suggests patients may also be at a higher risk for heart attacks*. DrugRisk is a resource...

2012-07-19 00:40:08

As severe sepsis becomes a silent epidemic among the elderly, greater mental health screenings may be necessary for spouses Severe sepsis, a body´s dangerous defensive response against an infection, not only diminishes the quality of life for patients — it puts their spouses at a greater risk of depression, a joint University of Michigan Health System and University of Washington School of Medicine study shows. Wives whose husbands were hospitalized for severe sepsis were...

2012-07-17 06:35:29

(Ivanhoe Newswire) --A drug used to treat sepsis that was once pulled for poisoning the blood, may be effective after all. The drug, known as drotrecogin alfa (activated) was approved for use in the United States in 2001, and in Europe in 2002, on the basis of the randomized, double-blind, placebo-controlled PROWESS study. Experts were concerned about the drug's efficacy and side-effects, and a second clinical study led to Eli Lilly withdrawing the drug in October 2011. The FDA made a...

2011-11-14 15:27:17

A recent study led by researchers at Boston University School of Medicine (BUSM) shows an increased risk of stroke and mortality among patients diagnosed with severe sepsis and new-onset atrial fibrillation (AF) during hospitalization. Allan J. Walkey, MD, assistant professor of medicine at BUSM and a pulmonologist at Boston Medical Center (BMC), is the lead author of the study, which will be published in the Journal of the American Medical Association. Walkey also will present the...

2011-11-08 06:47:57

(Ivanhoe Newswire) — A new drug commonly used to treat bleeding events in people with severe hemophilia can also be used to prevent such events from happening at all, according to this study. An international research team led by Dr. Cindy Leissinger of Tulane University School of Medicine, along with Dr. Alessandro Gringeri from the University of Milan, examined the ability of FEIBA to prevent bleeds in people with severe hemophilia A with inhibitors. People with this condition...

Word of the Day
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.